BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11979784)

  • 21. Using serum pepsinogens wisely in a clinical practice.
    Miki K; Urita Y
    J Dig Dis; 2007 Feb; 8(1):8-14. PubMed ID: 17261129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Helicobacter pylori eradication: always?--contra].
    Arnold R
    Dtsch Med Wochenschr; 2004 Jan; 129(1-2):43-4. PubMed ID: 14703582
    [No Abstract]   [Full Text] [Related]  

  • 23. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori infection, but not mucosal atrophy, significantly affects serum pepsinogen level after gastric cancer surgery.
    Onoda N; Katsuragi K; Maeda K; Sawada T; Wakasa K; Hirakawa K
    Hepatogastroenterology; 2006; 53(70):619-23. PubMed ID: 16995475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is GastroPanel serum assay useful in the diagnosis of Helicobacter pylori infection and associated gastritis in children?
    Koivusalo AI; Pakarinen MP; Kolho KL
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):35-8. PubMed ID: 16949782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Helicobacter pylori and gastric adenocarcinoma: definitely related?].
    Torrado J; Leal A
    Gastroenterol Hepatol; 1998 Jan; 21 Suppl 1():35-9. PubMed ID: 9549201
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of H. pylori infection on brain-gut peptide and acid secretion].
    Nakamura M; Tsuchimoto K; Ishii H
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():137-42. PubMed ID: 11979766
    [No Abstract]   [Full Text] [Related]  

  • 28. Inverse background of Helicobacter pylori antibody and pepsinogen in reflux oesophagitis compared with gastric cancer: analysis of 5732 Japanese subjects.
    Yamaji Y; Mitsushima T; Ikuma H; Okamoto M; Yoshida H; Kawabe T; Shiratori Y; Saito K; Yokouchi K; Omata M
    Gut; 2001 Sep; 49(3):335-40. PubMed ID: 11511553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Migrant communities constitute a possible target population for primary prevention of Helicobacter pylori-related complications in low incidence countries.
    De Vries AC; Van Driel HF; Richardus JH; Ouwendijk M; Van Vuuren AJ; De Man RA; Kuipers EJ
    Scand J Gastroenterol; 2008; 43(4):403-9. PubMed ID: 18365904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-1beta and IL-8, matrix metalloproteinase 3, and pepsinogen secretion before and after H. pylori eradication in gastroduodenal phenotypes.
    Chang YW; Oh HC; Jang JY; Hwangbo Y; Lee JW; Lee HJ; Joo KR; Dong SH; Kim SS; Kim HJ; Kim BH; Chang R
    Scand J Gastroenterol; 2008; 43(10):1184-93. PubMed ID: 18609140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Association between the level of serum pepsinogen I and markers of the Helicobacter pylori infection in teenagers].
    Reshetnikov OV; Kurilovich SA; Krotov SA; Krotova VA; Shumakova OV
    Eksp Klin Gastroenterol; 2004; (2):46-7, 109. PubMed ID: 15462321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Normalization of pH level and gastric mucosa after eradication of H. pylori in the remnant stomach.
    Kato S; Matsukura N; Matsuda N; Tsuchiya S; Naito Z; Tajiri T
    J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S258-61. PubMed ID: 19120908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Helicobacter pylori infection inhibits reflux esophagitis by inducing atrophic gastritis.
    Koike T; Ohara S; Sekine H; Iijima K; Kato K; Shimosegawa T; Toyota T
    Am J Gastroenterol; 1999 Dec; 94(12):3468-72. PubMed ID: 10606305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pepsinogen I and pepsinogen II, PG I/II ratio].
    Miki K; Sasajima M
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():778-81. PubMed ID: 20960872
    [No Abstract]   [Full Text] [Related]  

  • 35. [Atrophic gastritis caused by Helicobacter pylori as a precancer disease].
    Sklianskaia OA; Lapina TL
    Arkh Patol; 2004; 66(6):57-60. PubMed ID: 15648171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identifying Helicobacter pylori-associated gastritis, gastric atrophy and intestinal metaplasia with magnification endoscopy and adaptive index of haemoglobin enhancement technique.
    Anagnostopoulos GK; Ragunath K; Fortun PJ; Yao K
    Dig Liver Dis; 2005 Dec; 37(12):980-1; author reply 982. PubMed ID: 15975861
    [No Abstract]   [Full Text] [Related]  

  • 37. Sibship size, Helicobacter pylori infection and chronic atrophic gastritis: a population-based study among 9444 older adults from Germany.
    Gao L; Weck MN; Raum E; Stegmaier C; Rothenbacher D; Brenner H
    Int J Epidemiol; 2010 Feb; 39(1):129-34. PubMed ID: 19596750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastric plasma biomarkers and Operative Link for Gastritis Assessment gastritis stage.
    Daugule I; Sudraba A; Chiu HM; Funka K; Ivanauskas A; Janciauskas D; Jonaitis L; Kiudelis G; Tolmanis I; Vanags A; Lin JT; Kupcinskas L; Leja M
    Eur J Gastroenterol Hepatol; 2011 Apr; 23(4):302-7. PubMed ID: 21389862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Importance of biologic parameters in Helicobacter pylori gastritis: comparison with histological results].
    Abaza H; Ghanem A; Karoui J; Jmal A; Dhouib R; Harzallah L; Ben Mami N; Khaled R; Guemira F
    Ann Biol Clin (Paris); 2010; 68(4):473-9. PubMed ID: 20650743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The non-invasive diagnosis of precancerous changes of stomach mucosa.
    Pasechnikov VD; Chukov SZ; Kotelevets SM; Mostovov AN; Polyakova MB; Mernova VP
    Rocz Akad Med Bialymst; 2004; 49():66-71. PubMed ID: 15631316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.